CAPD peritonitis induces the production of a novel peptide, daintain/allograft inflammatory factor-1

Peritoneal Dialysis International

Volumn 23, Issue 1, 2003, Pages 5-13

  Brauner, Annelie ^b   Hertting, Olof ^b   Alkstrand, Eva ^b   Sandberg, Elvi ^a   Chromek, Milan ^b   Chen, Zheng Wang ^b,c   Östenson, Claes Göran ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Daintain allograft inflammatory factor 1; Escherichia coli; Macrophages; Monocytes; Peritonitis; Staphylococcus aureus; Staphylococcus epidermidis

Indexed keywords

ALLOGRAFT INFLAMMATORY FACTOR 1; GAMMA INTERFERON; INTERLEUKIN 1BETA; INTERLEUKIN 8; PEPTIDE;

ADULT; AGED; ARTICLE; BACTERIAL PERITONITIS; BACTERIAL VIRULENCE; CELL DIFFERENTIATION; CELL LINE; CLINICAL ARTICLE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; DIALYSATE; ENZYME IMMUNOASSAY; ESCHERICHIA COLI; FEMALE; FOLLOW UP; HOSPITAL ADMISSION; HUMAN; LEUKOCYTE ACTIVATION; MACROPHAGE ACTIVATION; MALE; MONOCYTE; PEPTIDE ANALYSIS; PEPTIDE SYNTHESIS; PERITONEAL FLUID; PRIORITY JOURNAL; RADIOIMMUNOASSAY; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STATISTICAL ANALYSIS; SUPERNATANT; SWEDEN;

EID: 12244284024     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686080302300101     Document Type: Article

References (28)

1. Rapoport J, Hausmann MJ, Chaimovitz C. The peritoneal immune system and continuous ambulatory peritoneal dialysis (Editorial). Nephron 1999; 81:373-80.
2. Topley N. The cytokine network controlling peritoneal inflammation. Perit Dial Int 1995; 15(Suppl 3):S35-9; Discussion, S39-40.
3. Davies SJ, Yewdall VM, Ogg CS, Cameron JS. Peritoneal defence mechanisms and Staphylococcus aureus in patients treated with continuous ambulatory peritoneal dialysis (CAPD). Perit Dial Int 1990; 10:135-40.
4. Lewis SL, Van Epps DE, Chenoweth DE. C5a receptor modulation on neutrophils and monocytes from chronic hemodialysis and peritoneal dialysis patients. Clin Nephrol 1986; 26:37-44.
5. Harvey DM, Sheppard KJ, Morgan AG, Fletcher J. Neutrophil function in patients on continuous ambulatory peritoneal dialysis. Br J Haematol 1988; 68: 273-8.
6. Goldstein CS, Bomalaski JS, Zurier RB, Neilson EG, Douglas SD. Analysis of peritoneal macrophages in continuous ambulatory peritoneal dialysis patients. Kidney Int 1984; 26:733-40.
7. Utans U, Arceci RJ, Yamashita Y, Russell ME. Cloning and characterization of allograft inflammatory factor-1: a novel macrophage factor identified in rat cardiac allografts with chronic rejection. J Clin Invest 1995; 95:2954-62.
8. Utans U, Quist WC, McManus BM, Wilson JE, Arceci RJ, Wallace AF, et al. Allograft inflammatory factor-1. A cytokine-responsive macrophage molecule expressed in transplanted human hearts. Transplantation 1996; 61:1387-92.
9. Postler E, Rimner A, Beschorner R, Schluesener HJ, Meyermann R. Allograft-inflammatory-factor-1 is upregulated in microglial cells in human cerebral infarctions [Corrected and republished in J Neuroimmunol 2000; 108(1-2):244-501. J Neuroimmunol 2000; 104:85-91.
10. Schluesener HJ, Seid K, Kretzschmar J, Meyermann R. Allograft-inflammatory factor-1 in rat experimental autoimmune encephalomyelitis, neuritis, and uveitis: expression by activated macrophages and microglial cells. Glia 1998; 24:244-51.
11. Schluesener HJ, Seid K, Meyermann R. Effects of autoantigen and dexamethasone treatment on expression of endothelial-monocyte activating polypeptide II and allograft-inflammatory factor-1 by activated macrophages and microglial cells in lesions of experimental autoimmune encephalomyelitis, neuritis and uveitis. Acta Neuropathol (Berl) 1999; 97:119-26.
12. Pashenkov M, Efendic S, Zhu J, Zou LP, Ostenson CG, Mustafa M. Augmented expression of daintain/allograft inflammatory factor-1 is associated with clinical disease: dynamics of daintain/allograft inflammatory factor-1 expression in spleen, peripheral nerves and sera during experimental autoimmune neuritis. Scand J Immunol 2000; 52:117-22.
13. Grimm PC, McKenna R, Nickerson P, Russell ME, Gough J, Gospodarek E, et al. Clinical rejection is distinguished from subclinical rejection by increased infiltration by a population of activated macrophages. J Am Soc Nephrol 1999; 10:1582-9.
14. McGregor SJ, Topley N, Jörres A, Speekenbrink AB, Gordon A, Gahl GM, et al. Longitudinal evaluation of peritoneal macrophage function and activation during CAPD: maturity, cytokine synthesis and arachidonic acid metabolism. Kidney Int 1996; 49:525-33.
15. Chen ZW, Ahren B, Ostenson CG, Cintra A, Bergman T, Moller C, et al. Identification, isolation, and characterization of daintain (allograft inflammatory factor 1), a macrophage polypeptide with effects on insulin secretion and abundantly present in the pancreas of pre-diabetic BB rats. Proc Natl Acad Sci USA 1997; 94: 13879-84.
16. Schluesener H. Generalized autoimmunity of the nervous system (GANS) induced by a recombinant protein composed of major pathogenic determinants of MBP, IRBP, and P2 protein: suppression of inflammation by a monoclonal antibody against activated rat T line cells. J Neurosci Res 1996; 45:303-7.
17. Schluesener HJ. The disintegrin domain of ADAM 8 enhances protection against rat experimental autoimmune encephalomyelitis, neuritis and uveitis by a polyvalent autoantigen vaccine. J Neuroimmunol 1998; 87:197-202.
18. Harlow E, Lane D. Antibodies: a Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory; 1988: 479-503.
19. Brauner A, Lu Y, Hallden G, Hylander B, Lundahl J. Difference in the blood monocyte phenotype between uremic patients and healthy controls: its relation to monocyte differentiation into macrophages in the peritoneal cavity. Inflammation 1998; 22:55-66.
20. Imai Y, Ibata I, Ito D, Ohsawa K, Kohsaka S. A novel gene iba1 in the major histocompatibility complex class III region encoding an EF hand protein expressed in a monocytic lineage. Biochem Biophys Res Commun 1996; 224:855-62.
21. Aguado BMC, Campbell RD. Genes of the MHC class III region and the functions of the proteins they encode. In: Browning M, McMichael A eds. HLA and MHC: Genes, Molecules and Function. Oxford: Bios Scientific Publishers; 1996: 39.
22. Neville MJ, Campbell RD. A new member of the Ig superfamily and a V-ATPase G subunit are among the predicted products of novel genes close to the TNF locus in the human MHC. J Immunol 1999; 162:4745-54.
23. Tanaka S, Suzuki K, Watanabe M, Matsuda A, Tone S, Koike T. Upregulation of a new microglial gene, mrf-1, in response to programmed neuronal cell death and degeneration. J Neurosci 1998; 18:6358-69.
24. Betjes MG, Tuk CW, Struijk DG, Krediet RT, Arisz L, Hoefsmit EC, et al. Immuno-effector characteristics of peritoneal cells during CAPD treatment: a longitudinal study. Kidney Int 1993; 43:641-8.
25. McGregor SJ, Brock JH, Briggs JD, Junor BJ. Release of hydrogen peroxide and expression of HLA-DR and transferrin receptors by monocytes and peritoneal macrophages from patients undergoing continuous ambulatory peritoneal dialysis and normal controls. Clin Immunol Immunopathol 1990; 56:151-8.
26. Peterson PK, Gaziano E, Suh HJ, Devalon M, Peterson L, Keane WF. Antimicrobial activities of dialysate-elicited and resident human peritoneal macrophages. Infect Immun 1985; 49:212-18.
27. Bos HJ, van Bronswijk H, Helmerhorst TJ, Oe PL, Hoefsmit EC, Beelen RH. Distinct subpopulations of elicited human macrophages in peritoneal dialysis patients and women undergoing laparoscopy: a study on peroxidatic activity. J Leukoc Biol 1988; 43:172-8.
28. Autieri MV. cDNA cloning of human allograft inflammatory factor-1: tissue distribution, cytokine induction, and mRNA expression in injured rat carotid arteries. Biochem Biophys Res Commun 1996; 228:29-37.